BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23512069)

  • 1. Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland.
    Fischer R; Collet TH; Zeller A; Zimmerli L; Gaspoz JM; Giraudon K; Rodondi N; Cornuz J
    Eur J Cancer Prev; 2013 Sep; 22(5):425-30. PubMed ID: 23512069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lower gastrointestinal endoscopy and fecal occult blood test in the 2007 Swiss Health Interview Survey respondents aged 50 years and older.
    Spaeth A; Zwahlen M
    Endoscopy; 2013 Jul; 45(7):560-6. PubMed ID: 23780844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN; Schenck AP; Davis WW
    Am J Prev Med; 2006 Apr; 30(4):313-9. PubMed ID: 16530618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal cancer screening among Mexican Americans at a community clinic.
    Yepes-Rios M; Reimann JO; Talavera AC; Ruiz de Esparza A; Talavera GA
    Am J Prev Med; 2006 Mar; 30(3):204-10. PubMed ID: 16476635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS; Forrest CB; Feng S; Mandelblatt J
    Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of self-reported history of colorectal cancer screening.
    Khoja S; McGregor SE; Hilsden RJ
    Can Fam Physician; 2007 Jul; 53(7):1192-7. PubMed ID: 17872816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of colorectal cancer screening from patients enrolled in a managed care health plan.
    Farmer MM; Bastani R; Kwan L; Belman M; Ganz PA
    Cancer; 2008 Mar; 112(6):1230-8. PubMed ID: 18266204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening among men and women in the United States.
    Peterson NB; Murff HJ; Ness RM; Dittus RS
    J Womens Health (Larchmt); 2007; 16(1):57-65. PubMed ID: 17324097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the choice of colorectal cancer screening tests in primary care settings from 7,845 prospectively collected surveys.
    Wong MC; John GK; Hirai HW; Lam TY; Luk AK; Ching JY; Ng SS; Chan FK; Griffiths SM; Sung JJ
    Cancer Causes Control; 2012 Sep; 23(9):1541-8. PubMed ID: 22836914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns.
    Schroy PC; Barrison AF; Ling BS; Wilson S; Geller AC
    Am J Gastroenterol; 2002 Apr; 97(4):1031-6. PubMed ID: 12008667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overweight, obesity, and colorectal cancer screening: disparity between men and women.
    Heo M; Allison DB; Fontaine KR
    BMC Public Health; 2004 Nov; 4():53. PubMed ID: 15533259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ; Cai Y; Green P; Beckett LA; Franks P; Baldwin LM
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening: physician attitudes and practices.
    Taylor ML; Anderson R
    WMJ; 2002; 101(5):39-43. PubMed ID: 12239980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstacles to colorectal cancer screening in Chinese: a study based on the health belief model.
    Sung JJ; Choi SY; Chan FK; Ching JY; Lau JT; Griffiths S
    Am J Gastroenterol; 2008 Apr; 103(4):974-81. PubMed ID: 18047545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening.
    Almog R; Ezra G; Lavi I; Rennert G; Hagoel L
    Eur J Cancer Prev; 2008 Oct; 17(5):430-7. PubMed ID: 18714185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of self-reported colorectal cancer (CRC) screening in a study of ethnically diverse first-degree relatives of CRC cases.
    Bastani R; Glenn BA; Maxwell AE; Ganz PA; Mojica CM; Chang LC
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):791-8. PubMed ID: 18381469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colonoscopy is the preferred colorectal cancer screening method in a population-based program.
    Marbet UA; Bauerfeind P; Brunner J; Dorta G; Valloton JJ; Delcò F
    Endoscopy; 2008 Aug; 40(8):650-5. PubMed ID: 18609465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening in Canada: results of a national survey.
    Sewitch MJ; Fournier C; Ciampi A; Dyachenko A
    Chronic Dis Can; 2008; 29(1):9-21. PubMed ID: 19036219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population-based estimate of the extent of colorectal cancer screening in Ontario.
    Rabeneck L; Paszat LF
    Am J Gastroenterol; 2004 Jun; 99(6):1141-4. PubMed ID: 15180738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.